Related content

A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis

By Gold Deborah T.   Martin Bradley C.   Frytak Jennifer R.   Amonkar Mayur M.   Cosman Felicia  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 585-594

Informa Healthcare

Access to resources Recommend Favorite

Performance of COLIA1 Polymorphism and Bone Turnover Markers to Identify Postmenopausal Women with Prevalent Vertebral Fractures

By Mezquita-Raya P.   Muñoz-Torres M.   de Dios Luna J.   Lopez-Rodriguez F.   Quesada J. M.   Luque-Recio F.   Escobar-Jiménez F.  

Osteoporosis International, Vol. 13, Iss. 6, 2002-06 ,pp. : 506-512

Springer Publishing Company

Access to resources Recommend Favorite

Menopausal and bone risk assessments in postmenopausal women

By Sikon Andrea  

Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 2, 2005-06 ,pp. : 115-123

Humana Press, Inc

Access to resources Recommend Favorite

The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial

By Bhattoa H.   Bettembuk P.   Balogh A.   Szegedi G.   Kiss E.  

Osteoporosis International, Vol. 15, Iss. 5, 2004-05 ,pp. : 396-404

Springer Publishing Company

Access to resources Recommend Favorite

Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer

By Bell R.   Lewis J.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1045-1051

Informa Healthcare

Access to resources Recommend Favorite